Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • NPPA Fixes Ceiling...

NPPA Fixes Ceiling Prices for 8 IV Fluids with packages having special features

Dr. Divya ColinWritten by Dr. Divya Colin Published On 2023-04-30T10:00:35+05:30  |  Updated On 30 April 2023 10:00 AM IST
NPPA Fixes Ceiling Prices for 8 IV Fluids with packages having special features
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: Through a recent notification drug price regulator, the National Pharmaceutical Pricing Authority (NPPA) has revised and fixed the ceiling price of the eight 8 IV Fluids with packages having special features of Schedule-I (NLEM 2015) under Drugs (Prices Control) Order,2013.

According to the new prices notified by the drug price regulator, the ceiling price of Glucose Injection 5% 1000ml NonGlass with special features is Rs.95.10, Glucose Injection 5% 500ml Non-Glass with special features is Rs.82.27, Glucose plus Sodium Chloride Injection 5% plus 0.9% 1000ml Non-Glass with special features is Rs.99.93, Glucose plus Sodium Chloride Injection 5% plus 0.9% 500ml Non-Glass with special features is Rs. 85.51, Sodium Chloride Injection 0.9%100ml Non-Glass with special features is Rs.42.05, Sodium Chloride Injection 0.9%250ml Non-Glass with special features is Rs.62.10, Sodium Chloride Injection 0.9% 500ml Non-Glass with special features is Rs.87.93 and Sodium Chloride Injection 0.9% 1000ml Non-Glass with special features is Rs.98.49.

The notice declared that in exercise of powers, conferred by sub paragraph (3) and (4) of paragraph 11, 14 and 16 of the Drugs (Prices Control) Order, 2013, read with S.O.1394(E) dated the 30th May, 2013, S.O. 1192(E) dated 22nd March, 2016, S.O.5249(E) dated 11th November, 2022 issued by the Government of India in the Ministry of Chemicals and Fertilizers and in supersession of the order of the Government of India in the Ministry of Chemicals and Fertilizers (National Pharmaceutical Pricing Authority) S.O. No. 1500(E) dated 30.03.2022 andS.O.4591(E) dated 29.09.2022in so far as they relate to formulation packs mentioned in the Table A below, manufactured by the manufacturers specified in Table B for specified products and pack-sizes, except in respect of things done or omitted to be done before such supersession, the National Pharmaceutical Pricing Authority, has revised the price based on Wholesale price index(WPI) of 2022 as specified in column (5) of the Table A herein below as separate ceiling price exclusive of Goods and Services Tax applicable, if any, in respect of the scheduled formulations specified in the corresponding entry in column (2) of the said Table with the dosage form and strength and unit/packaging specified respectively in the corresponding entries in columns (3) and (4) thereof:

Sl. No

Medicines

Dosage Form and Strength

Unit

Ceiling price (w.e.f.01.04.2023 with WPI @ 12.1218%)

(1)

(2)

(3)

(4)

(5)

1

Glucose

Injection 5%

1000ml NonGlass

with special features

95.10

2

Glucose

Injection 5%

500ml Non-Glass with special features

82.27

3

Glucose (A)+ Sodium Chloride (B)

Injection 5% (A)

+ 0.9% (B)

1000ml Non-Glass with special features

99.93

4

Glucose (A)+ Sodium Chloride (B)

Injection 5% (A)

+ 0.9% (B)

500ml Non-Glass with special features

85.51


5

Sodium Chloride

Injection 0.9%

100ml Non-Glass with special

features

42.05

6

Sodium Chloride

Injection 0.9%

250ml Non-Glass with special

features

62.10

7

Sodium Chloride

Injection 0.9%

500ml Non-Glass

with special features

87.93

8

Sodium Chloride

Injection 0.9%

1000ml Non-Glass

with special features

98.49

TABLE ‘B’

Sl.

No.

Name of Manufacturer

Product /Brand Name

(1)

(2)

(3)

1

M/s B.Braun Medical (I) Pvt Ltd.

Ecoflac Plus bottle with Eurohead

2

M/s Amanta Healthcare Ltd.

Steriport bottle

3

M/s Aculife Healthcare Pvt Ltd.

Aculife bottle with Eurohead

4

M/s Albert David Limited

Albert David bottle with Eurohead

5

M/s Denis Chem Limited

Aquapulse with Eurohead

6

M/s Claris Life Sciences Limited

Clari's bottle with Eurohead

7

M/s Fresenius Kabi India Pvt Limited

Freeflex bags

8

M/s Otsuka Pharmaceutical India Private Ltd. (previously known as Claris Otsuka Private Limited)

Unibag

9

M/s Aishwarya Lifesciences

LifusionEurohead bottle

10

M/s Baxter (India) Pvt. Ltd.

Viaflex bags

11

M/s Otsuka Pharmaceutical India Private Ltd. (previously known as Claris Otsuka Private Limited)

Eurohead bottle

12

M/s Fresenius Kabi India Pvt Limited

Eurohead bottle

13

M/s AxaParenterals Ltd

Steri Drip bottle with Eurohead

14

M/s Shree Krishna Keshav Laboratories Ltd

Easyport bottle with Eurohead

15

M/s Rusoma Laboratories Pvt. Ltd.

Puradrip

16

M/s R. K. Laboratories Pvt. Ltd.

Eurohead bottle

17

M/s Eurolife Healthcare Pvt. Ltd.

Life port

18

M/s RealcadeLifesciencePvt. Ltd.

Euro head bottle

19

M/s Puniska Healthcare Pvt. Ltd [Note (b) below]

Non –PVC bag

20

M/s Abaris Healthcare Pvt. Ltd

Duo Port

21

M/s Higgs Healthcare [Note (c) below]

Aqua Drip

22

M/s Rusoma Laboratories Pvt. Ltd.

Eurohead Bottles with Brand name “Dewdrip”

23

M/s Puerto Life Sciences Private Limited [Note (d) below]

Euro head bottle


24

M/s Sachin Parenteral Pvt. Ltd. [Note (e) below]

“SAFE PORT”

The notice further added:

(a) The ceiling prices are applicable with effect from 01.04.2023 (ceiling prices are inclusive of Wholesale Price Index (WPI) @12.1218% for the year 2022 over 2021).
(b) In the case of M/s Puniska Healthcare Pvt. Ltd. mentioned in Sl. No. 19 of Table B, only the prices of the formulations specified in Sl. No. 5, 6, 7 & 8 of Table A are applicable.
(c) In the case of M/s Higgs Healthcare mentioned in Sl. No. 21 of Table B, only the prices of the formulations specified in Sl. No. 1, 2, 3, 4, 5, 7 & 8 of Table A are applicable.
(d) In the case of M/s Puerto Life Sciences Private Limited mentioned in Sl. No. 23 of Table B, only the prices of the formulations specified in Sl. No. 2, 4 & 7 of Table A are applicable.
(e) In the case of M/s Sachin Parenteral Pvt. Ltd. mentioned in Sl. No. 24 of Table B, only the prices of the formulations specified in Sl. No. 2, 4, 5, 6 & 7 of Table A are applicable.
(f) The manufacturers of scheduled formulations, selling abovesaid products/brand name of scheduled formulations at a price higher than the ceiling price (plus Goods and Services Tax as applicable) so fixed and notified by the Government, shall revise the prices of all such formulations downward not exceeding the ceiling price specified in column (5) in the above table plus Goods and Services Tax as applicable, if any.
(g) The manufacturers of the above-mentioned scheduled formulations having MRP lower than the ceiling price notified vide S.O. No. 1500(E) dated 30.03.2022 and S.O. No. 4591(E) dated 29.09.2022(plus Goods and Services Tax as applicable, if any), may revise the existing M.R.P. of their formulations, on the basis of WPI @ 12.1218% for the year 2022 over 2021 in accordance with paragraph 16(2) of DPCO, 2013.
(h) The manufacturers may add Goods and Services Tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above-said table.
(i) Any other manufacturer claiming a separate ceiling price for Non-Glass with a special feature shall apply to NPPA for separate ceiling price approval with details and demonstrate, that such pack along with documentation and demonstration.
(j) Information about the revision, if carried out, shall be forwarded to the Government in either electronic or physical form in Form-II within a period of fifteen days of such revision, and non-submission of the information under this subparagraph shall be construed as a non revision of maximum retail price (MRP) and the concerned manufacturer shall be liable to deposit the amount charged over and above the pre-revised maximum retail price (MRP), along with interest thereon from the date of overcharging.
(k) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from the date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
Also Read:CDSCO Drug Alert: 48 drug samples flagged not of standard quality
NPPAceiling priceIV fluidglucose injectionsodium chloride injectionprice fixation
Dr. Divya Colin
Dr. Divya Colin

    Doctor of Pharmacy

    Dr. Divya Colin, a Doctor of Pharmacy Graduate with extensive experience in clinical and hospital settings and confidently equipped with diagnostic and therapeutic skills. She also has spread out exposure to Oncology Departments in Mysore Medical College and Research Institute as Oncology Pharmacist. Currently she is building a career in clinical research and clinical data management. She has been a part of Medical Dialogue since January 2022.

    Show Full Article
    Next Story

    Editorial

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Male Smokers Aged 40-45 Years with Hypertension: Identifying the Ideal Candidates

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    View All

    Journal Club Today

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    Global Omega-3 Shortage Poses Serious Health and Environmental Risks: Study

    View All

    Health News Today

    Health Bulletin 31/May/2025

    Health Bulletin 31/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok